Clovis Oncology Buy Hold or Sell Recommendation

CLVSDelisted Stock  USD 0.09  0.02  24.00%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Clovis Oncology is 'Not Rated'. Macroaxis provides Clovis Oncology buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CLVS positions. The advice algorithm takes into account all of Clovis Oncology's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Clovis Oncology's buy or sell advice are summarized below:
Real Value
0.0884
Hype Value
0.09
Market Value
0.093
Naive Value
0.13
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Clovis Oncology given historical horizon and risk tolerance towards Clovis Oncology. When Macroaxis issues a 'buy' or 'sell' recommendation for Clovis Oncology, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
In addition, we conduct extensive research on individual companies such as Clovis and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Clovis Oncology. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

Execute Clovis Oncology Buy or Sell Advice

The Clovis recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Clovis Oncology. Macroaxis does not own or have any residual interests in Clovis Oncology or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Clovis Oncology's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Clovis OncologyBuy Clovis Oncology
Not Rated
For the selected time horizon Clovis Oncology has a Risk Adjusted Performance of (0.03), Jensen Alpha of (1.00), Total Risk Alpha of (1.90) and Treynor Ratio of (0.69)
We provide trade advice to complement the prevailing expert consensus on Clovis Oncology. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Clovis Oncology is not overpriced, please confirm all Clovis Oncology fundamentals, including its gross profit and the relationship between the debt to equity and retained earnings . As Clovis Oncology appears to be a penny stock we also recommend to validate its price to earning numbers.

Clovis Oncology Trading Alerts and Improvement Suggestions

Clovis Oncology is not yet fully synchronised with the market data
Clovis Oncology has some characteristics of a very speculative penny stock
Clovis Oncology has a very high chance of going through financial distress in the upcoming years
Clovis Oncology has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
The company reported the previous year's revenue of 148.76 M. Net Loss for the year was (264.52 M) with profit before overhead, payroll, taxes, and interest of 115.3 M.
Clovis Oncology currently holds about 94.58 M in cash with (196.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.65, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

Clovis Oncology Returns Distribution Density

The distribution of Clovis Oncology's historical returns is an attempt to chart the uncertainty of Clovis Oncology's future price movements. The chart of the probability distribution of Clovis Oncology daily returns describes the distribution of returns around its average expected value. We use Clovis Oncology price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Clovis Oncology returns is essential to provide solid investment advice for Clovis Oncology.
Mean Return
-0.93
Value At Risk
-15.38
Potential Upside
20.97
Standard Deviation
13.24
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Clovis Oncology historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Clovis Oncology Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Clovis . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Clovis Oncology Buy or Sell Advice

When is the right time to buy or sell Clovis Oncology? Buying financial instruments such as Clovis Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Clovis Oncology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run USD Crypto Fund Thematic Idea Now

USD Crypto Fund
USD Crypto Fund Theme
Fund from digital currency traded on multiple global exchanges in US dollors. The USD Crypto Fund theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize USD Crypto Fund Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Consideration for investing in Clovis Stock

If you are still planning to invest in Clovis Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Clovis Oncology's history and understand the potential risks before investing.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
CEOs Directory
Screen CEOs from public companies around the world
Commodity Directory
Find actively traded commodities issued by global exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Share Portfolio
Track or share privately all of your investments from the convenience of any device
FinTech Suite
Use AI to screen and filter profitable investment opportunities